M&A M&A
US-based Senores Pharma to buy 2 ANDAs from Teva Pharmaceuticals
Source Business Line (opens in a new tab)BSE Announcement (opens in a new tab)
Ahmedabad-based Senores Pharmaceuticals Ltd (SPL), through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA (SPI), is to acquire 2 Abbreviated New Drug Applications (ANDAs) from Teva Pharmaceuticals USA , Inc.The addressable opportunity of the acquired ANDAs in the USA is approximately USD 38 million (MAT December 2024) according to IQVIA and USD 120 million (MAT June 2025). The acquisition will be funded through the Initial Public Offer (IPO) proceeds raised by SPL.